3.5(top 10%)
impact factor
102(top 100%)
papers
1.3K(top 50%)
citations
20(top 50%)
h-index
3.5(top 10%)
extended IF
128
all documents
1.5K
doc citations
32(top 50%)
g-index

Top Articles

#TitleJournalYearCitations
1<p>Alzheimer’s Disease – Why We Need Early Diagnosis</p>Degenerative Neurological and Neuromuscular Disease2019181
2Biomarkers of multiple sclerosis: current findingsDegenerative Neurological and Neuromuscular Disease201779
3The genetics of amyotrophic lateral sclerosis: current insightsDegenerative Neurological and Neuromuscular Disease201665
4Amyotrophic lateral sclerosis: update and new developmentsDegenerative Neurological and Neuromuscular Disease201262
5Randomized control trial evaluation of a modified Paleolithic dietary intervention in the treatment of relapsing-remitting multiple sclerosis: a pilot studyDegenerative Neurological and Neuromuscular Disease201753
6Biomarkers of Duchenne muscular dystrophy: current findingsDegenerative Neurological and Neuromuscular Disease201852
7Riluzole: real-world evidence supports significant extension of median survival times in patients with amyotrophic lateral sclerosisDegenerative Neurological and Neuromuscular Disease201750
8

Progressive Multifocal Leukoencephalopathy: Current Insights

Degenerative Neurological and Neuromuscular Disease201943
9Juvenile neuronal ceroid lipofuscinosis (Batten disease): current insightsDegenerative Neurological and Neuromuscular Disease201639
10Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategiesDegenerative Neurological and Neuromuscular Disease201837
11Physical therapy for individuals with amyotrophic lateral sclerosis: current insightsDegenerative Neurological and Neuromuscular Disease201831
12Cell adhesion molecules in Alzheimer's diseaseDegenerative Neurological and Neuromuscular Disease201230
13Effects of a multimodal intervention on gait and balance of subjects with progressive multiple sclerosis: a prospective longitudinal pilot studyDegenerative Neurological and Neuromuscular Disease201728
14<p>The effects of huntingtin-lowering: what do we know so far?</p>Degenerative Neurological and Neuromuscular Disease201928
15Neurodegeneration in multiple sclerosis involves multiple pathogenic mechanismsDegenerative Neurological and Neuromuscular Disease201426
16Spotlight on postural control in patients with multiple sclerosisDegenerative Neurological and Neuromuscular Disease201826
17Poststroke cognitive impairment and dementia: prevalence, diagnosis, and treatmentDegenerative Neurological and Neuromuscular Disease201425
18Employment of patients with multiple sclerosis: the influence of psychosocial-structural coping and contextDegenerative Neurological and Neuromuscular Disease201825
19Multimodal intervention improves fatigue and quality of life in subjects with progressive multiple sclerosis: a pilot studyDegenerative Neurological and Neuromuscular Disease201523
20Respiratory management of patients with neuromuscular disease: current perspectivesDegenerative Neurological and Neuromuscular Disease201623
21Efficacy of stem cell therapy in ambulatory and nonambulatory children with Duchenne muscular dystrophy &ndash; Phase I&ndash;IIDegenerative Neurological and Neuromuscular Disease201823
22<p>Prostaglandins as the Agents That Modulate the Course of Brain Disorders</p>Degenerative Neurological and Neuromuscular Disease202023
23<p>Sialorrhea in patients with ALS: current treatment options</p>Degenerative Neurological and Neuromuscular Disease201920
24Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventionsDegenerative Neurological and Neuromuscular Disease201719
25Optical coherence tomography for retinal imaging in multiple sclerosisDegenerative Neurological and Neuromuscular Disease201418
26Clinical potential of ataluren in the treatment of Duchenne muscular dystrophyDegenerative Neurological and Neuromuscular Disease201618
27<p>Dysphagia In Multiple Sclerosis Patients: Diagnostic And Evaluation Strategies</p>Degenerative Neurological and Neuromuscular Disease202017
28Deep brain stimulation for the treatment of Parkinson’s disease: efficacy and safetyDegenerative Neurological and Neuromuscular Disease201215
29Cladribine tablets&rsquo; potential role as a key example of selective immune reconstitution therapy in multiple sclerosisDegenerative Neurological and Neuromuscular Disease201815
30<p>Advances in Newborn Screening and Presymptomatic Diagnosis of Spinal Muscular Atrophy</p>Degenerative Neurological and Neuromuscular Disease202014
31Bioactive Compounds and Traditional Herbal Medicine: Promising Approaches for the Treatment of DementiaDegenerative Neurological and Neuromuscular Disease202114
32The epidemiology and pathophysiology of pseudobulbar affect and its association with neurodegenerationDegenerative Neurological and Neuromuscular Disease201313
33Music and dementiaDegenerative Neurological and Neuromuscular Disease201313
34Current concepts in multiple sclerosis therapyDegenerative Neurological and Neuromuscular Disease201713
35Palliative care for patients with motor neurone disease: current challengesDegenerative Neurological and Neuromuscular Disease201612
36<p>Lambert-Eaton Myasthenic syndrome: early diagnosis is key</p>Degenerative Neurological and Neuromuscular Disease201911
37<p>Re-Evaluating the Use of IFN-β and Relapsing Multiple Sclerosis: Safety, Efficacy and Place in Therapy</p>Degenerative Neurological and Neuromuscular Disease202011
38Potential Roles of Glucagon-Like Peptide-1 and Its Analogues in Dementia Targeting Impaired Insulin Secretion and NeurodegenerationDegenerative Neurological and Neuromuscular Disease202211
39Pathogenic mechanisms of neurodegeneration based on the phenotypic expression of progressive forms of immune-mediated neurologic diseaseDegenerative Neurological and Neuromuscular Disease201210
40<p>Clinical and research applications of neuromuscular ultrasound in amyotrophic lateral sclerosis</p>Degenerative Neurological and Neuromuscular Disease201910
41Melatonin Improves Short-Term Spatial Memory in a Mouse Model of Alzheimer’s DiseaseDegenerative Neurological and Neuromuscular Disease202110
42Update on pediatric dystonias: etiology, epidemiology, and managementDegenerative Neurological and Neuromuscular Disease20129
43Clinical utility of DaTscan&trade; (123I-Ioflupane Injection) in the diagnosis of Parkinsonian SyndromesDegenerative Neurological and Neuromuscular Disease20139
44Axonal transport and neurodegenerative disease: vesicle-motor complex formation and their regulationDegenerative Neurological and Neuromuscular Disease20149
45Detection of neuropathy using a sudomotor test in type 2 diabetesDegenerative Neurological and Neuromuscular Disease20159
46

Effect of the micro-immunotherapy medicine 2LPARK® on rat primary dopaminergic neurons after 6-OHDA injury: oxidative stress and survival evaluation in an in vitro model of Parkinson’s disease

Degenerative Neurological and Neuromuscular Disease20199
47Epigenetic mechanisms in Alzheimer's diseaseDegenerative Neurological and Neuromuscular Disease20148
48Continuous noninvasive ventilation for respiratory failure in patients with amyotrophic lateral sclerosis: current perspectivesDegenerative Neurological and Neuromuscular Disease20188
49

Efficacy, safety, and quality-of-life of treatments for acute relapses of multiple sclerosis: results from a literature review of randomized controlled trials

Degenerative Neurological and Neuromuscular Disease20198
50Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical DataDegenerative Neurological and Neuromuscular Disease20228